Primary Intraocular T-cell Lymphoma
10.3341/jkos.2019.60.6.594
- Author:
Yong Il SHIN
1
;
Ju Mi KIM
;
Jong Joo LEE
;
Jung Yeul KIM
;
Jinman KIM
;
Young Joon JO
Author Information
1. Department of Ophthalmology, Chungnam National University College of Medicine, Daejeon, Korea. youngjoonjo@gmail.com
- Publication Type:Case Report
- Keywords:
Corneal epitheliopathy;
Methotrexate;
Primary intraocular T-cell lymphoma
- MeSH:
Diagnosis;
Follow-Up Studies;
Humans;
Intraocular Lymphoma;
Intravitreal Injections;
Lymphoma;
Lymphoma, B-Cell;
Lymphoma, T-Cell;
Male;
Methotrexate;
Middle Aged;
Retinaldehyde;
T-Lymphocytes;
Vitrectomy
- From:Journal of the Korean Ophthalmological Society
2019;60(6):594-599
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Intraocular lymphoma can be divided into primary and secondary usually involving B-cell lymphoma. Intraocular T-cell lymphoma is mostly secondary lymphoma while primary intraocular T-cell lymphoma is extremely rare. We report a case of primary T-cell lymphoma. CASE SUMMARY: A 62-year-old male without any systemic disease presented with a floater in the right eye. A fundus examination showed multiple whitish retinal infiltrations in the right eye. Intraocular lymphoma was suspected, and systemic examination was performed, but all results were normal. During steroid treatment, previous lesions were enlarged, new lesions developed, and a diagnosis of primary T-cell lymphoma was made by diagnostic vitrectomy. Consecutive intravitreal injections of methotrexate were performed. After eight injections, the vitreous and retinal lesions improved but we decided to terminate the injections due to corneal epitheliopathy. The corneal epitheliopathy was recovered and the patient is currently undergoing periodic follow-ups without progression of the lesion. CONCLUSIONS: Although intraocular T-cell lymphoma is a rare condition, this primary T-cell type should be considered when an intraocular lymphoma lesion is suspected.
